27796450|t|Quantification of urinary mono-hydroxylated metabolites of polycyclic aromatic hydrocarbons by on-line solid phase extraction - high performance liquid chromatography-tandem mass spectrometry
27796450|a|Human exposure to polycyclic aromatic hydrocarbons (PAHs) can be assessed through monitoring of urinary mono-hydroxylated PAHs (OH-PAHs). Gas chromatography (GC) has been widely used to separate OH-PAHs before quantification by mass spectrometry in biomonitoring studies. However, because GC requires derivatization, it can be time consuming. We developed an on-line solid phase extraction coupled to isotope dilution - high performance liquid chromatography-tandem mass spectrometry (on-line-SPE - HPLC-MS / MS) method for the quantification in urine of 1-OH-naphthalene, 2-OH-naphthalene, 2-OH-fluorene, 3-OH-fluorene, 1-OH-phenanthrene, the sum of 2-OH and 3-OH-phenanthrene, 4-OH-phenanthrene, and 1-OH-pyrene. The method, which employed a 96- well plate platform and on-line SPE, showed good sensitivity (i.e., limits of detection ranged from 0.007 to 0.09 ng/mL) and used only 100 Î¼L of urine. Accuracy, calculated from the recovery percentage at three spiking levels, varied from 94 to 113 %, depending on the analyte. The inter - and intra - day precision, calculated from 20 repeated measurements of two quality control materials, varied from 5.2 to 16.7 %. Adequate method performance was also confirmed by acceptable recovery (83-102 %) of two NIST standard reference materials (3672 and 3673). This high-throughput on-line-SPE - HPLC-MS / MS method can be applied in large - scale epidemiological studies. Graphical abstract Example LC-MS chromatogram of urinary mono-hydroxylated PAH metabolites.
27796450	0	14	Quantification	T081	C1709793
27796450	18	25	urinary	T080	C1524119
27796450	26	55	mono-hydroxylated metabolites	T123	C0870883
27796450	59	91	polycyclic aromatic hydrocarbons	T109	C0032458
27796450	95	125	on-line solid phase extraction	T059	C1720880
27796450	128	191	high performance liquid chromatography-tandem mass spectrometry	T059	C4054772
27796450	192	197	Human	T016	C0086418
27796450	198	209	exposure to	T080	C0332157
27796450	210	242	polycyclic aromatic hydrocarbons	T109	C0032458
27796450	244	248	PAHs	T109	C0032458
27796450	257	265	assessed	T052	C1516048
27796450	274	284	monitoring	T058	C1283169
27796450	288	295	urinary	T080	C1524119
27796450	296	318	mono-hydroxylated PAHs	T109	C0032458
27796450	320	327	OH-PAHs	T109	C0032458
27796450	330	348	Gas chromatography	T059	C0008555
27796450	350	352	GC	T059	C0008555
27796450	378	386	separate	T080	C0443299
27796450	387	394	OH-PAHs	T109	C0032458
27796450	402	416	quantification	T081	C1709793
27796450	420	437	mass spectrometry	T059	C0037813
27796450	441	454	biomonitoring	T057	C0005517
27796450	455	462	studies	T062	C2603343
27796450	481	483	GC	T059	C0008555
27796450	493	507	derivatization	T169	C0449851
27796450	519	533	time consuming	T080	C3827829
27796450	538	547	developed	T169	C1527148
27796450	551	581	on-line solid phase extraction	T059	C1720880
27796450	582	589	coupled	T169	C1948027
27796450	593	600	isotope	T196	C0022262
27796450	601	609	dilution	T169	C1948037
27796450	612	675	high performance liquid chromatography-tandem mass spectrometry	T059	C4054772
27796450	677	688	on-line-SPE	T059	C1720880
27796450	691	698	HPLC-MS	T059	C4054772
27796450	701	703	MS	T059	C0037813
27796450	705	711	method	T170	C0025663
27796450	720	734	quantification	T081	C1709793
27796450	738	743	urine	T031	C0042036
27796450	747	763	1-OH-naphthalene	T109,T121	C0027375
27796450	765	781	2-OH-naphthalene	T109,T121	C0027375
27796450	783	796	2-OH-fluorene	T109,T131	C0060517
27796450	798	811	3-OH-fluorene	T109,T131	C0060517
27796450	813	830	1-OH-phenanthrene	T109	C0031367
27796450	843	847	2-OH	T109	C0031367
27796450	852	869	3-OH-phenanthrene	T109	C0031367
27796450	871	888	4-OH-phenanthrene	T109	C0031367
27796450	894	905	1-OH-pyrene	T109	C0072667
27796450	911	917	method	T170	C0025663
27796450	925	933	employed	T033	C0557351
27796450	940	959	well plate platform	T082	C4283957
27796450	964	975	on-line SPE	T059	C1720880
27796450	984	1000	good sensitivity	T067	C2346484
27796450	1008	1014	limits	T169	C0439801
27796450	1018	1027	detection	T061	C1511790
27796450	1028	1034	ranged	T081	C1514721
27796450	1085	1090	urine	T031	C0042036
27796450	1092	1100	Accuracy	T080	C0443131
27796450	1102	1112	calculated	T059	C1443182
27796450	1122	1130	recovery	T052	C0237820
27796450	1131	1141	percentage	T081	C0439165
27796450	1151	1158	spiking	T082	C0348018
27796450	1159	1165	levels	T080	C0441889
27796450	1167	1173	varied	T080	C0205419
27796450	1192	1201	depending	T080	C1701901
27796450	1209	1216	analyte	T167	C0443354
27796450	1222	1227	inter	T079	C1548610
27796450	1234	1239	intra	T079	C0347985
27796450	1242	1255	day precision	T078	C1561539
27796450	1257	1267	calculated	T059	C1443182
27796450	1276	1284	repeated	T169	C0205341
27796450	1285	1297	measurements	T169	C0242485
27796450	1305	1320	quality control	T169	C0034378
27796450	1321	1330	materials	T167	C0520510
27796450	1332	1338	varied	T080	C0205419
27796450	1359	1367	Adequate	T080	C0205411
27796450	1368	1374	method	T170	C0025663
27796450	1375	1386	performance	T052	C1882330
27796450	1396	1408	confirmed by	T080	C0521093
27796450	1409	1419	acceptable	T080	C1879533
27796450	1420	1428	recovery	T052	C0237820
27796450	1447	1451	NIST	T092	C0021622
27796450	1452	1470	standard reference	T081	C0034925
27796450	1471	1480	materials	T167	C0520510
27796450	1503	1518	high-throughput	T170	C0872047
27796450	1519	1530	on-line-SPE	T059	C1720880
27796450	1533	1540	HPLC-MS	T059	C4054772
27796450	1543	1545	MS	T059	C0037813
27796450	1546	1552	method	T170	C0025663
27796450	1571	1576	large	T081	C0549177
27796450	1579	1584	scale	T077	C1522412
27796450	1585	1608	epidemiological studies	T062	C0002783
27796450	1610	1628	Graphical abstract	T170	C0870616
27796450	1637	1655	LC-MS chromatogram	T169	C1883002
27796450	1659	1666	urinary	T080	C1524119
27796450	1667	1688	mono-hydroxylated PAH	T109	C0032458
27796450	1689	1700	metabolites	T123	C0870883